## KKR: KKR & Co. Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-8.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($123.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Mizuho Financial Group buys out KKR, takes charge of Avendus**
- Source: The Economic Times | 20251217T090928 | Bullish | Relevance: 100%
- Mizuho Financial Group has acquired a controlling stake in Indian investment bank Avendus, allowing KKR to exit its nine-year-old investment. The deal values Avendus at ₹5,900 crore, translating to a 3.5x return for KKR. Avendus's co-founders Gaurav Deepak and Kaushal Aggarwal will retain operational control.

**2. KKR Invests $220M in Premialab for Global Expansion**
- Source: GuruFocus | 20251216T110013 | Somewhat-Bearish | Relevance: 100%
- KKR has invested $220 million in Premialab, a data and analytics company for quantitative investing, to accelerate its international growth. This investment comes as KKR, a leading alternative asset manager, faces concerns regarding declining revenue growth and profitability margins. Despite a strong balance sheet liquidity, KKR's financial health is under scrutiny due to a high debt-to-equity ratio and an Altman Z-Score in the distress zone.

**3. KKR (NYSE: KKR) puts $220m into Premialab in first Gulf deal for NGT fund**
- Source: Stock Titan | 20251216T083314 | Bullish | Relevance: 100%
- KKR has invested $220 million in Premialab, a global provider of data, analytics, and risk management solutions for quantitative investing. This strategic investment, made through KKR's Next Generation Technology Growth Fund III, marks the fund's first deal in the Gulf region. The capital will support Premialab's global expansion, operational system development, and the scaling of its newly launched execution product with Eurex, aiming to enhance its position as a market standard for Quantitative Investment Strategies (QIS).

**4. HASI and KKR Commit Additional $1 Billion to CarbonCount Holdings 1**
- Source: TradingView — Track All Markets | 20251215T220820 | Bullish | Relevance: 100%
- HASI and KKR have committed an additional $500 million each, totaling $1 billion, to CarbonCount Holdings 1 LLC (CCH1), a co-investment vehicle for sustainable infrastructure projects. This new capital commitment, combined with existing leverage targets, will expand CCH1's total investment capacity to nearly $5 billion. The investment vehicle's period has also been extended until the end of 2027 or until all commitments are utilized, aiming to further support the energy transition and address rising power demand in the U.S.

**5. HASI and KKR Commit Additional $1 Billion to CarbonCount Holdings 1**
- Source: Markets Financial Content | 20251215T161500 | Bullish | Relevance: 100%
- HASI and KKR have committed an additional $1 billion to CarbonCount Holdings 1 LLC (CCH1), a co-investment vehicle for sustainable infrastructure projects in the US. This new capital commitment, $500 million from each firm, will expand CCH1's total investment capacity to nearly $5 billion and extend its investment period. The move reflects strong momentum and the partners' conviction in the growing opportunity for clean energy investments.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $169 | $154 | +10% |
| 2025-12-11 | UBS | $176 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-11 | UBS | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($5.74M) |
| Sells | 2 ($424.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 6.7% (+1.0%)
- Blackrock Inc.: 5.4% (-1.1%)
- Capital Internationa: 3.5% (-1.4%)
- State Street Corpora: 3.1% (+1.6%)
- Wellington Managemen: 2.7% (+1.3%)

### Key Risks

1. High beta (2.00) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $424M sold (2 transactions in 90 days).
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.58 indicates undervaluation relative to growth. Forward P/E 19.5x attractive for 32% earnings growth. Balance sheet: strong liquidity (4.2x), $2.4B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment positive (1 raises, avg +10%). Insider selling cluster ($424.4M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $122.4B |
| Beta | 2.00 |
| 52W Range | $86.15 - $170.40 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.58 |
| Forward P/E | 19.5 |
| Current P/E | 25.7 |
| YoY Growth | 32.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 9.2% to 1.1% (-8.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 (-0.9%) diverging from MRS_10 - short-term weakness emerging. Underperforming sector by 3.4pp, stock-specific weakness. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.67), confirming momentum. RSI neutral at 57. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.09% (CS: 36) | Neutral |
| RSI_14 | 56.6 | Neutral |
| MACD Histogram | 0.67 | Bullish |
| vs SMA20 | 1.037x | Above |
| vs SMA50 | 1.073x | Above |
| vs SMA200 | 1.043x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $132.16
- **Stop Loss:** $123.60 (6.5% risk)
- **Target:** $140.72 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 126
- **Position Value:** $16,652.16
- **Portfolio %:** 16.65%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-06 (Est: $1.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.41 | +8.6% |
| 2025Q2 | $1.14 | $1.18 | +3.6% |
| 2025Q1 | $1.13 | $1.15 | +1.7% |
| 2024Q4 | $1.28 | $1.32 | +3.5% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*